Get Free Delivery With No Minimum Order

SUPRAX D 400MG 6TAB
- Sku : I-023397
Key features
SUPRAX D 400MG 6TAB is a dispersible tablet containing the third‑generation cephalosporin antibiotic cefixime 400 mg. It inhibits bacterial cell wall synthesis by binding to penicillin‑binding proteins, disrupting peptidoglycan formation and leading to bacterial cell death. It is indicated for uncomplicated urinary tract infections, otitis media, pharyngitis, tonsillitis, acute exacerbations of chronic bronchitis, and uncomplicated cervical or urethral gonorrhea. Available as dispersible tablets in packs of 6 tablets; prescription only.- Brand: SUPRAX
- Active Ingredient: CEFIXIME 400mg
- Strength: 400mg
- Dosage Form: Dispersible tablet
- Pack Size: 6 Tablets
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Anti-infective
- Pharmacological Group: Third-generation Cephalosporins
- Drug Class: Third-generation Cephalosporin Antibiotic
- Manufacturer: Jazeera Pharmaceutical Industries (JPI)
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 1911246257
- Shelf Life: 24 months
- Storage: store below 30°c
- Spectrum: Broad-spectrum.
- Antibiotic Class: Cephalosporin
Indications
Approved Uses
Uncomplicated urinary tract infections, otitis media, pharyngitis, tonsillitis, acute exacerbations of chronic bronchitis, uncomplicated gonorrhea (cervical/urethral)
Dosage & Administration
Dosing by Condition
Adults (typical): 400 mg once daily or 200 mg every 12 hours for most susceptible infections; uncomplicated gonorrhea: 400 mg single dose (where still recommended/locally appropriate). Duration depends on indication (commonly 5-14 days).
Initial Dose
400mg once daily or 200mg twice daily
Maintenance Dose
400mg once daily or 200mg every 12 hours.
Maximum Dose
400mg per day.
Children's Dosage
Children 6 months to 12 years or ≤50kg: 8mg/kg/day as a single dose or divided every 12 hours (max 400mg/day). Children >50kg or >12 years: adult dose applies. Oral suspension preferred for children
Dose Adjustment Notes
Dose reduction/extended interval is required in renal impairment (e.g., CrCl <60 mL/min); no routine dose adjustment is required in hepatic impairment.
How to Take
Oral use: Disperse the 400 mg dispersible tablet in a small amount of water, stir, and drink immediately; then rinse the glass with a little water and drink. May also be swallowed whole with water if needed. Can be taken with or without food.
How to Prepare
For the dispersible tablet (cefixime 400 mg): place the tablet in a small amount of water (e.g., a glass), allow it to disperse completely, stir, and drink immediately; rinse the glass with a little more water and drink to ensure the full dose is taken (alternatively, it may be swallowed whole with water if permitted by the product leaflet).
Side Effects
Common Side Effects
Diarrhea/loose stools, nausea, abdominal pain, dyspepsia, vomiting, flatulence (gas), headache; rash can occur.
Side Effect Frequency
Common (≥1% to <10%): diarrhea/loose stools, abdominal pain, nausea. Uncommon (≥0.1% to <1%): vomiting, flatulence/dyspepsia, headache/dizziness, rash/urticaria, pruritus, transient liver enzyme elevations. Rare/very rare (<0.1%): severe hypersensitivity (including anaphylaxis), severe cutaneous adverse reactions (SJS/TEN), Clostridioides difficile-associated diarrhea/pseudomembranous colitis, blood dyscrasias (e.g., thrombocytopenia, agranulocytosis).
Safety & Warnings
Contraindications
Contraindicated in patients with hypersensitivity to cefixime or other cephalosporins; avoid in those with a history of severe immediate hypersensitivity to other beta‑lactams (e.g., penicillins) unless benefits outweigh risks.
Warnings & Precautions
Caution with history of penicillin/beta‑lactam allergy; monitor for C. difficile diarrhea during/after therapy; adjust dose in renal impairment; prolonged use may cause superinfection; caution in GI disease/colitis; may cause false‑positive urine glucose with copper-reduction tests.
Age Restriction
Safety and efficacy not established in infants <6 months; use only if clearly needed under specialist direction.
Drug Interactions
Drug Interactions
Warfarin/coumarins (↑INR/bleeding risk), carbamazepine (↑levels), probenecid (↑cefixime exposure), live oral typhoid vaccine (reduced vaccine response-avoid/space).
Interaction Severity
MAJOR/clinically significant: Warfarin (may increase INR/bleeding-monitor closely). MODERATE: Live oral typhoid vaccine Ty21a (antibiotics can reduce vaccine efficacy-avoid during and for several days after antibiotics), Carbamazepine (may increase levels-monitor). MINOR/MODERATE: Probenecid (may increase cefixime concentrations).
Food Interaction
No restriction: may be taken with or without food; taking with food may improve GI tolerability.
Special Populations
Children
Children 6 months to 12 years or ≤50kg: 8mg/kg/day as a single dose or divided every 12 hours (max 400mg/day). Children >50kg or >12 years: adult dose applies. Oral suspension preferred for children
Elderly
Standard adult dosing; monitor renal function as age-related decline in renal function may necessitate dose adjustment
Kidney Impairment
CrCl 21-60 mL/min: 75% of the normal daily dose (e.g., 300 mg/day). CrCl ≤20 mL/min or dialysis: 50% of the normal daily dose (e.g., 200 mg/day).
Liver Impairment
No adjustment needed.
Storage & Patient Advice
Preparation Instructions
For the dispersible tablet (cefixime 400 mg): place the tablet in a small amount of water (e.g., a glass), allow it to disperse completely, stir, and drink immediately; rinse the glass with a little more water and drink to ensure the full dose is taken (alternatively, it may be swallowed whole with water if permitted by the product leaflet).
Stopping the Medicine
Complete the full prescribed antibiotic course; do not stop early without prescriber advice.
Overdose
No specific antidote; provide supportive care (consider activated charcoal if recent ingestion). Hemodialysis/peritoneal dialysis do not remove cefixime in significant amounts.
Patient Counseling
Take exactly as prescribed and complete the full course; disperse the tablet in a small amount of water and drink immediately (or swallow whole if needed); may take with food if stomach upset occurs; seek care urgently for allergy symptoms (rash, swelling, breathing difficulty) or severe/persistent diarrhea (possible C. difficile); inform clinician about penicillin/cephalosporin allergy and warfarin use.
Monitoring Requirements
No routine labs for short courses in healthy patients; monitor renal function in patients with significant renal impairment and monitor for severe diarrhea/C. difficile and superinfection with prolonged therapy; check INR more frequently if on warfarin.
Pharmacology
Mechanism of Action
Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), which disrupts the final step of peptidoglycan synthesis, leading to bacterial cell death.
Onset of Action
Peak plasma concentration (Tmax) typically occurs about 2-6 hours after an oral dose; clinical improvement is usually assessed over 48-72 hours depending on infection.
Duration of Effect
Approximately 24 hours, allowing for once-daily dosing.
Half-Life
3-4 hours.
Bioavailability
Oral bioavailability is approximately 40-50%; the oral suspension may provide modestly higher bioavailability than tablets in some studies.
Metabolism
Not significantly metabolized; largely excreted unchanged.
Excretion
Eliminated primarily via the kidneys; about ~50% of the absorbed dose is excreted unchanged in urine, with the remainder via non-renal routes (including biliary/fecal).
Protein Binding
Approximately 65-70% protein bound.
Product Information
Available Dosage Forms
For this SFDA-registered product: dispersible tablet (400 mg). Other cefixime dosage forms that may exist in general include capsules, film-coated tablets, chewable tablets, and powder for oral suspension (market-dependent).
Composition per Dose
Each dispersible tablet: 400mg cefixime (as cefixime trihydrate)
Generic Availability
Yes
OTC Alternatives
No OTC alternative - prescription antibiotic required
Spectrum
Broad-spectrum.
Antibiotic Class
Cephalosporin
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)

